Category: Postbiotics & Probiotics

  • Autism and the Gut Microbiome: New Research and the Potential of Postbiotics

    The relationship between autism and the gut microbiome has become one of the most active areas of research connecting gastrointestinal health, immunology, and neuroscience.

    Why do children with autism frequently experience digestive problems? How does the gut microbiome influence gastrointestinal symptoms, and what opportunities could emerging postbiotic technologies offer?

    Several studies published in October 2026 provide new insights into these questions.

    Their findings highlight connections between gut bacteria, feeding behavior, digestive comfort, and the complex communication network known as the gut–immune–brain axis.

    Why Gut Health Matters in Autism

    Gastrointestinal difficulties are common among children with autism spectrum disorder (ASD).

    Frequently reported problems include:

    • Constipation and irregular bowel movements.
    • Abdominal bloating and excessive gas.
    • Abdominal pain and discomfort.
    • Diarrhea.
    • Food selectivity and feeding difficulties.
    • Sleep disturbances associated with digestive discomfort.

    For children who have difficulty communicating physical sensations, identifying gastrointestinal discomfort can be particularly challenging.

    Pain or digestive problems may sometimes appear as increased irritability, restlessness, changes in behavior, or disrupted sleep.

    This makes digestive health an important component of overall well-being.

    Researchers are increasingly investigating whether differences in the intestinal microbiome help explain some of these gastrointestinal symptoms.

    New 2026 Study: Gut Microbiome and Feeding Behavior in 140 Children

    On October 23, 2026, the Journal of Clinical Medicine Research published a study examining gut microbiota, feeding difficulties, and markers associated with intestinal barrier function in children with autism.

    The study included:

    • 70 children with autism, aged 3–12.
    • 70 typically developing children in a comparison group.

    Researchers analyzed selected intestinal bacterial populations, feeding and mealtime behavior, and fecal markers associated with the intestinal environment.

    What Did the Researchers Discover?

    1. Differences in beneficial bacterial populations

    Children with ASD demonstrated lower levels of certain bacterial groups, including Bifidobacterium, Lactobacillus, and Prevotella.

    These microorganisms have attracted scientific interest because of their roles in the intestinal ecosystem.

    2. Changes in other microbial populations

    Researchers also identified differences involving other bacteria, including increased levels of Clostridioides difficile.

    3. Higher levels of selected intestinal markers

    The ASD group showed higher fecal zonulin and calprotectin levels than the comparison group.

    These findings contributed to the researchers’ interest in potential relationships between microbial composition, intestinal barrier function, and gastrointestinal health.

    An Important Connection With Feeding Difficulties

    One particularly interesting finding involved the relationship between intestinal bacteria and feeding behavior.

    Within the ASD group, lower Bifidobacterium levels were associated with more pronounced feeding difficulties.

    Higher Clostridioides difficile levels were also associated with greater difficulties during mealtimes.

    Interestingly, these feeding problems did not show a significant relationship with overall autism severity in the study.

    The results suggest that gut microbial patterns may be linked to specific feeding challenges rather than simply reflecting the severity of autism symptoms.

    This creates an interesting research opportunity focused on the intestinal environment and digestive comfort.

    Another October 2026 Study: Gut Bacteria and Digestive Symptoms

    A separate study published on October 14, 2026, in Pediatric Research examined the relationship between gut microbiota and gastrointestinal symptoms in children with ASD.

    Researchers identified differences in microbial composition and diversity, along with associations between particular bacterial groups and symptoms such as:

    • Flatulence.
    • Abdominal discomfort.
    • Changes in stool characteristics.
    • Diarrhea.
    • Nighttime awakening.

    The findings offer further evidence that intestinal microbial patterns may be related to gastrointestinal experiences in children with autism.

    The study did not find evidence of elevated intestinal inflammation across the biomarkers examined, illustrating the complexity of these biological relationships.

    Together, the October studies reinforce growing scientific interest in the role of the intestinal microbiome in digestive health among children with ASD.

    The Gut–Immune–Brain Axis: A New Research Direction

    On October 21, 2026, Microbiome Research Reports published an article examining the interaction between the gut microbiome, immune system, and brain in autism.

    This interconnected communication network is commonly described as the gut–immune–brain axis.

    Gut microorganisms interact with the intestinal environment and participate in biological processes involving microbial metabolites, cellular signaling, and immune responses.

    Researchers are exploring how these processes may relate to nervous system function.

    Of particular interest are microbial structures and biologically active components that can interact with immune pathways.

    This growing field is expanding the understanding of the intestinal microbiome beyond digestion alone.

    Why Are Researchers Interested in Postbiotics?

    For years, probiotics—preparations containing live microorganisms—have attracted attention as a potential approach to supporting intestinal microbial balance.

    A newer field focuses on postbiotics, which are preparations of inanimate microorganisms and/or their components that provide a health benefit.

    Unlike conventional probiotics, postbiotics do not depend on maintaining bacterial viability during manufacturing, storage, or consumption.

    This creates opportunities to develop standardized microbial preparations.

    Researchers are investigating postbiotic approaches in several areas:

    • Supporting a balanced intestinal environment.
    • Studying interactions with intestinal barrier function.
    • Exploring immune regulatory mechanisms.
    • Supporting digestive comfort without introducing live bacterial cultures.

    These possibilities are particularly interesting in the context of sensitive gastrointestinal systems.

    Learn more about the differences between the two approaches in our article Postbiotics vs. Probiotics: Why Postbiotics Are the Next Generation.

    What Do Clinical Studies of Postbiotics Show?

    In September 2026, Frontiers in Nutrition published a randomized, double-blind, placebo-controlled trial investigating beLP1, a heat-inactivated preparation of Lactiplantibacillus plantarum.

    The study enrolled 140 adults with excess body weight and ongoing gastrointestinal discomfort.

    Participants received postbiotic supplementation or placebo for 84 days.

    The study reported several encouraging outcomes among participants receiving beLP1:

    • Reduced overall gastrointestinal symptom severity.
    • Improvements in abdominal pain.
    • Better digestive comfort.
    • Lower perceived stress.
    • Favorable changes in selected gut bacterial populations.

    The findings are particularly interesting because these changes occurred without introducing living probiotic microorganisms.

    The research contributes to a growing scientific foundation for developing standardized postbiotic formulations focused on digestive health.

    For families interested in the relationship between autism and gastrointestinal well-being, this broader direction of postbiotic research is worth following.

    Read our detailed clinical research overview: Postbiotics for Gut Health: What Clinical Studies Reveal.

    NBH Postbiotic Pro: A Three-Component Approach to Gut Health

    Modern research into the gut microbiome, intestinal barrier function, and immune regulation helped shape the development of NBH Postbiotic Pro.

    Developed by NBHemp, this three-component postbiotic formula combines:

    ES1 + beLP1 + pAkk11

    The components were selected to represent complementary directions in postbiotic research.

    The formula focuses on three priorities.

    1. Supporting the Gut Microbial Environment

    Maintaining a balanced intestinal environment is an important consideration for people with sensitive digestive systems.

    2. Supporting Intestinal Barrier Function

    The intestinal barrier plays a central role in interactions between intestinal contents, microbial structures, and the body’s internal environment.

    3. Supporting Normal Immune Regulation

    The emerging gut–immune–brain research field highlights the importance of communication between microorganisms and immune pathways.

    These principles are reflected in the development concept behind:

    NBH Postbiotic Pro — GUT BARRIER + IMMUNE CALM

    The formulation was developed with particular attention to people with sensitive digestion, including the gastrointestinal challenges that families of children with autism and epilepsy may encounter.

    As research into microbial components and intestinal health expands, multi-component postbiotic formulations offer an increasingly interesting direction for further investigation.

    How Gut Health Can Affect Everyday Well-Being

    Digestive comfort matters far beyond the process of food digestion.

    For people experiencing recurring abdominal pain, constipation, bloating, or other gastrointestinal symptoms, improved digestive well-being can make everyday activities more comfortable.

    This is especially relevant for children who may have difficulty describing pain or discomfort.

    Identifying gastrointestinal problems and understanding their possible relationship with the intestinal microbiome can help guide research and discussions about digestive support.

    Conclusion

    Autism and the gut microbiome represent an important area of research connecting gastroenterology, immunology, and neuroscience.

    Studies published in October 2026 identified meaningful relationships between intestinal microbial patterns, feeding difficulties, and gastrointestinal symptoms in children with ASD.

    At the same time, researchers continue to investigate the gut–immune–brain axis and the potential role of microbial components in intestinal health.

    These discoveries provide a promising scientific framework for the continued development of postbiotic technologies.

    NBH Postbiotic Pro represents this approach through a combination of three selected postbiotic components designed around microbiome support, intestinal barrier function, and normal immune regulation.


    Scientific References

    1. Ali WH, et al. (2026).

    Targeted Quantitative Polymerase Chain Reaction Analysis of Gut Microbiota and Its Association With Feeding and Mealtime Behavior and Intestinal Permeability in Children With Autism Spectrum Disorder.

    Journal of Clinical Medicine Research, 18(10), 759–769.

    https://doi.org/10.14740/jocmr6687

    2. Harne V, et al. (2026).

    Gut microbiota are linked to gastrointestinal symptoms and behavioral changes but not inflammation in autism spectrum disorder: a cross-sectional analysis.

    Pediatric Research.

    https://doi.org/10.1038/s41390-026-05548-6

    3. Park JC, Im S-H. (2026).

    New insights into the gut-immune-brain axis: immune mechanisms and therapeutic targets for autism spectrum disorder.

    Microbiome Research Reports, 5:26.

    https://doi.org/10.20517/mrr.2026.48

    4. Manoharan RK, et al. (2026).

    Gut health and microbiome modulation by the heat-killed postbiotic beLP1® in adults with excess weight: a randomized, placebo-controlled trial.

    Frontiers in Nutrition, 13:1919277.

    https://doi.org/10.3389/fnut.2026.1919277

    5. Salminen S, et al. (2021).

    The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics.

    Nature Reviews Gastroenterology & Hepatology.

    https://doi.org/10.1038/s41575-021-00440-6
  • Postbiotics for Gut Health: What Clinical Studies Reveal

    Postbiotics are emerging as one of the most promising developments in modern gut health research. Unlike traditional probiotics, which rely on living microorganisms, postbiotics use inactivated microorganisms and their components to interact with the intestinal environment.

    Can postbiotics improve digestion, reduce abdominal discomfort, and support a healthier gut microbiome?

    Several clinical studies published in 2026 have brought new evidence to this rapidly developing field.

    The findings include a randomized clinical trial involving 140 adults, an eight-week intervention in older adults, and a systematic review of postbiotic use in irritable bowel syndrome.

    What Are Postbiotics, and Why Are They Important for Gut Health?

    Postbiotics are preparations of inanimate microorganisms and/or their components that provide a health benefit.

    Unlike live probiotics, postbiotics do not require microorganisms to remain alive during storage or after consumption.

    Their activity can involve microbial cell structures and interactions with the intestinal environment.

    Researchers are particularly interested in three areas:

    • Supporting digestive comfort and normal gastrointestinal function.
    • Promoting favorable changes in the gut microbiome.
    • Exploring interactions with the intestinal barrier and immune regulation.

    Because postbiotic preparations can be standardized without maintaining live bacterial viability, they offer an attractive platform for developing next-generation gut health products.

    A 2026 Clinical Trial: 140 Participants and 84 Days

    On September 17, 2026, Frontiers in Nutrition published a randomized, double-blind, placebo-controlled trial investigating beLP1, a heat-inactivated preparation of Lactiplantibacillus plantarum.

    The study enrolled 140 adults aged 18–45 with excess body weight and a history of mild-to-moderate gastrointestinal discomfort.

    Participants received either beLP1 or placebo daily for 84 days. The primary per-protocol analysis included 103 participants.

    What Did the Researchers Find?

    Compared with placebo, participants receiving beLP1 experienced several positive outcomes.

    1. Reduced overall gastrointestinal symptoms

    Scores on the Gastrointestinal Symptom Rating Scale (GSRS) improved significantly by Day 42, with the benefit maintained through Day 84.

    2. Less abdominal pain

    By the end of the trial, the beLP1 group showed significantly greater improvements in abdominal pain than the placebo group.

    3. Improved digestive comfort

    The study also found improvements in symptoms related to dyspepsia and upper digestive discomfort.

    4. Reduced perceived stress

    Participants receiving beLP1 reported significantly lower perceived stress scores.

    5. Better digestion-related quality of life

    Improvements were also observed in a questionnaire measuring the impact of digestive symptoms on daily life.

    These findings suggest that the benefits of selected postbiotic preparations may extend beyond individual digestive symptoms to broader measures of well-being.

    How Did the Gut Microbiome Change?

    Researchers examined the participants’ intestinal microbiome before and after the intervention.

    The beLP1 group demonstrated favorable changes in several microbial populations associated with digestive and metabolic health.

    These included increased representation of organisms such as Bifidobacterium longum, Faecalibacterium prausnitzii, and members of the genus Blautia.

    Researchers also reported reductions in certain opportunistic microorganisms, including Escherichia coli and Klebsiella pneumoniae.

    Some of the enriched bacteria are associated with the production of short-chain fatty acids, compounds involved in the complex relationship between intestinal microorganisms and the gut environment.

    This is particularly interesting because the administered postbiotic contained inactivated microorganisms rather than live bacteria.

    The results illustrate how microbial components may help influence the existing gut ecosystem without introducing living bacterial cultures.

    Postbiotics and Digestive Health in Older Adults

    A separate randomized, double-blind study published in Molecular Nutrition & Food Research in September 2026 investigated postbiotic supplementation in 48 older adults living in long-term care facilities.

    Participants received either a postbiotic preparation or placebo for eight weeks.

    The researchers observed:

    • Better bowel regularity.
    • Fewer episodes of diarrhea.
    • Reduced reliance on laxatives.
    • Favorable shifts in gut microbiome composition.
    • Improvements in selected systemic inflammatory indicators.

    These findings are especially relevant to healthy aging.

    Changes in intestinal microbial communities, bowel habits, and digestive comfort become increasingly important as people grow older.

    Postbiotic technology offers a promising way to explore digestive support using standardized preparations of inactivated microorganisms.

    Postbiotics and Irritable Bowel Syndrome

    Irritable bowel syndrome (IBS) is a common gastrointestinal condition associated with abdominal pain, altered bowel habits, and digestive discomfort.

    A 2026 systematic review and meta-analysis examined four randomized controlled trials involving 1,062 adults with IBS.

    The researchers evaluated gastrointestinal symptom severity, abdominal pain, quality of life, and safety outcomes.

    Their analysis identified encouraging signals for selected postbiotic interventions, particularly regarding symptom severity and abdominal discomfort.

    The growing body of research supports continued investigation of postbiotic formulations designed for sensitive digestive systems.

    Why Are Postbiotics an Attractive Alternative to Traditional Probiotics?

    Conventional probiotics rely on live microorganisms.

    Postbiotics take a different approach by using inactivated microorganisms and biologically active microbial structures.

    This creates several practical advantages for formulation development:

    • Standardized microbial composition.
    • No requirement to maintain bacterial viability during storage.
    • Convenient manufacturing, handling, and transportation.
    • No dependence on the introduced microorganisms surviving or multiplying in the digestive tract.

    These characteristics make postbiotics particularly interesting for people seeking predictable, convenient approaches to everyday digestive support.

    For a closer comparison, read our article Postbiotics vs. Probiotics: Why Postbiotics Are the Next Generation.

    How Does This Research Relate to NBH Postbiotic Pro?

    NBH Postbiotic Pro is a three-component postbiotic formula developed by NBHemp around emerging research in gut microbiome science, intestinal barrier function, and immune regulation.

    Its formulation combines three selected postbiotic components:

    ES1, beLP1, and pAkk11.

    Each component represents a complementary area of research into the interaction between inactivated microorganisms and intestinal health.

    One particularly relevant connection is beLP1, the subject of the September 2026 clinical trial involving 140 adults.

    The positive findings from that study provide an important scientific foundation for the development of advanced postbiotic formulas incorporating this component.

    NBH Postbiotic Pro was designed around three complementary priorities:

    GUT BARRIER + IMMUNE CALM + MICROBIOME SUPPORT

    The concept is to bring together multiple postbiotic components in one standardized formula, with particular attention to digestive comfort and people with sensitive gastrointestinal systems.

    As research continues to reveal new biological mechanisms and practical applications, multidimensional formulations such as NBH Postbiotic Pro represent an exciting direction for modern gut health innovation.

    What Do the Clinical Findings Tell Us?

    The studies published in 2026 highlight several important developments.

    First, selected postbiotic preparations demonstrated improvements in digestive comfort and abdominal pain.

    Second, researchers observed favorable changes in gut microbial communities without administering live bacteria.

    Third, an intervention involving older adults showed improvements in bowel function and selected inflammatory markers.

    Finally, controlled studies and systematic reviews are helping build a stronger foundation for understanding postbiotics in people with functional gastrointestinal symptoms.

    Together, these findings support the growing scientific and commercial interest in postbiotic technology.

    Conclusion

    Postbiotics for gut health are becoming an increasingly important area of clinical research.

    Studies published in 2026 reported encouraging outcomes in digestive comfort, abdominal pain, bowel regularity, and microbiome composition.

    These advances offer a strong rationale for continued development of multifunctional postbiotic formulas.

    NBH Postbiotic Pro brings this emerging research direction into a three-component formulation designed around intestinal barrier support, normal immune regulation, and a balanced gut environment.


    Scientific References

    1. Manoharan RK, et al. (2026).

    Gut health and microbiome modulation by the heat-killed postbiotic beLP1® in adults with excess weight: a randomized, placebo-controlled trial.

    Frontiers in Nutrition, 13:1919277.

    https://doi.org/10.3389/fnut.2026.1919277

    2. Bravo M, et al. (2026).

    Postbiotic Intervention Improves Bowel Function and Promotes Systemic Health in Institutionalized Older Adults.

    Molecular Nutrition & Food Research, 70(18).

    https://doi.org/10.1002/mnfr.70610

    3. Efficacy and Safety of Postbiotics in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis (2026).

    Journal of Gastroenterology and Hepatology.

    https://pubmed.ncbi.nlm.nih.gov/42103684

    4. Salminen S, et al. (2021).

    The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics.

    Nature Reviews Gastroenterology & Hepatology.

    https://doi.org/10.1038/s41575-021-00440-6
  • How to Remove Microplastics from Your Body: Can Postbiotics Help?

    Microplastics are increasingly being detected in drinking water, food, air, and even human tissues. As research reveals how widespread exposure has become, a question is attracting growing attention: How can we remove microplastics from the body, and can gut health play a role?

    A September 2026 scientific study opened a promising new direction: using postbiotics—preparations derived from inactivated microorganisms—to bind micro- and nanoplastic particles in the digestive environment.

    The results suggest that certain postbiotic structures can interact with plastic particles and reduce their contact with intestinal cells.

    What Are Microplastics, and How Do They Enter the Body?

    Microplastics are plastic particles smaller than 5 millimeters. Even smaller particles, generally below 1 micrometer, are commonly described as nanoplastics.

    They originate from the breakdown of larger plastic products and from sources such as synthetic textiles, packaging, tires, and other consumer materials.

    Humans may encounter these particles through food, drinking water, and inhaled dust.

    Research has identified microplastics in various biological samples and tissues. Scientists are now investigating how smaller particles interact with the intestinal barrier, immune system, and other biological structures.

    How Does the Body Get Rid of Microplastics?

    The digestive tract is both an important route of exposure and a natural route through which some ingested plastic particles leave the body.

    Larger particles may pass through without entering tissues. Smaller particles, particularly nanoplastics, may interact with cells and potentially cross biological barriers.

    This raises an interesting possibility: Could binding plastic particles inside the digestive tract help limit their interaction with the intestinal lining?

    Researchers are exploring this question using selected microorganisms and postbiotic preparations.

    A 2026 Breakthrough: Postbiotics Bind Nanoplastic Particles

    On September 21, 2026, Frontiers in Microbiology published a study titled Postbiotic sequestration of micro- and nanoplastics: in vitro intestinal epithelial protection and proof of concept in the human mouth.

    The researchers investigated Qi601, a preparation derived from heat-inactivated Limosilactobacillus fermentum.

    Laboratory experiments examined its interaction with fluorescent polystyrene nanoplastic particles approximately 100 nanometers in diameter.

    Finding 1: Up to 92% Reduction in Free Nanoplastic Signal

    In a laboratory model simulating sequential digestion, Qi601 reduced the fluorescence signal of freely suspended nanoplastic particles in the liquid fraction by approximately 92%.

    The researchers interpreted the findings as consistent with substantial binding, or sequestration, of nanoplastics by the postbiotic material.

    This suggests that microbial structures may have value as physical binding agents within the gastrointestinal environment.

    Finding 2: Reduced Interaction with Intestinal Cells

    The researchers also evaluated interactions between plastic particles and Caco-2 cells, a widely used laboratory model of the intestinal epithelium.

    After five hours, the experiments demonstrated approximately:

    • 65% lower particle-associated fluorescence at the cell surface.
    • 67% lower intracellular particle-associated fluorescence.

    These results support the possibility that postbiotic materials could reduce contact between selected nanoplastic particles and intestinal cells.

    Finding 3: Plastic Binding in the Human Mouth

    The researchers conducted an exploratory experiment involving chewing gum and a postbiotic preparation.

    Analysis of collected saliva provided preliminary evidence of physical interactions between postbiotic material and particles associated with chewing gum.

    Together, the laboratory and exploratory findings suggest that microbial components can interact with plastic particles in several biological environments.

    Why Are Postbiotics Especially Interesting?

    Scientists have previously investigated whether living probiotic bacteria can bind microplastic particles.

    Postbiotics offer a different technological approach.

    Because they contain inactivated microorganisms or their components, their application does not depend on maintaining live bacterial viability.

    Their cellular structures, including components of bacterial surfaces, may participate in interactions with substances found in the digestive environment.

    The potential advantages of postbiotic technology include:

    • Standardized microbial preparations.
    • No requirement to maintain living bacteria.
    • Opportunities to investigate physical particle-binding mechanisms.
    • Compatibility with research focused on intestinal barrier function and gut health.

    This emerging field expands the scientific interest in postbiotics beyond traditional discussions of digestion and the gut microbiome.

    Learn more about the differences between these approaches in our article Postbiotics vs. Probiotics: Why Postbiotics Are the Next Generation.

    What Does This Mean for NBH Postbiotic Pro?

    The development of advanced postbiotic formulations is an important direction in modern microbiome science.

    NBH Postbiotic Pro, developed by NBHemp, combines three selected postbiotic components: ES1, beLP1, and pAkk11.

    Its formulation was designed around three complementary priorities:

    • Supporting a balanced intestinal environment.
    • Supporting healthy intestinal barrier function.
    • Supporting normal immune regulation.

    Research into how postbiotic materials interact with environmental particles introduces another promising direction for exploring multifunctional postbiotic formulations.

    An especially interesting question is whether combinations such as those used in NBH Postbiotic Pro might offer additional interactions within the intestinal environment alongside their intended gut-support functions.

    As scientific understanding of postbiotic structures develops, these possibilities may become increasingly relevant to future research.

    Practical Ways to Reduce Microplastic Exposure

    While scientists investigate biological approaches, reducing unnecessary exposure remains useful.

    Practical measures include avoiding unnecessary heating of food in plastic containers, using appropriate materials for hot foods and beverages, and reducing reliance on disposable plastic products where practical.

    Attention to the intestinal environment also remains important as researchers continue to investigate how microorganisms and their components interact with ingested substances.

    The Future of Postbiotics and Microplastic Research

    The September 2026 study highlights a promising mechanism: certain postbiotic preparations can bind nanoplastic particles in laboratory conditions and reduce their interaction with intestinal cell models.

    That finding opens new questions about postbiotic technology, intestinal protection, and interactions between microbial components and environmental particles.

    For multifunctional formulations such as NBH Postbiotic Pro, this developing field offers an additional area of scientific interest.

    The broader opportunity is to understand how carefully selected postbiotic components can contribute to a healthier intestinal environment in a world where exposure to microplastics is increasingly common.


    Scientific References

    1. Berkes EA, Oron O, Wood A, Monsul PN, Monsul NT. (2026).
    Postbiotic sequestration of micro- and nanoplastics: in vitro intestinal epithelial protection and proof of concept in the human mouth. Frontiers in Microbiology, 17:1881786.

    https://doi.org/10.3389/fmicb.2026.1881786

    2. U.S. Government Accountability Office. (2026).
    Science & Tech Spotlight: Microplastics in the Body and Environment. GAO-26-109098.

    https://www.gao.gov/products/gao-26-109098

    3. Salminen S, et al. (2021).
    The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nature Reviews Gastroenterology & Hepatology.

    https://doi.org/10.1038/s41575-021-00440-6
  • Why Do Probiotics Cause Bloating and Gas? Causes and Solutions

    Probiotics are taken to improve digestion and support the gut microbiome. But sometimes people experience the opposite: bloating, excess gas, a feeling of fullness, and abdominal discomfort after starting a supplement.

    Why do probiotics cause gas and bloating when they are supposed to support gut health?

    This is a recognized problem. The U.S. National Institutes of Health (NIH) lists gas among the possible side effects of probiotics.

    The causes vary, from individual responses of the gut microbiota to additional ingredients in the product itself.

    Here is what the science tells us, how to identify the likely source of the problem, and why the search for alternatives to conventional probiotics helped drive the development of postbiotics.

    Five reasons probiotics can cause bloating

    1. Changes in gut microbial activity

    Probiotics contain selected microorganisms that interact with the existing gut ecosystem.

    Everyone’s gut microbiota is different. Bacterial composition, digestive characteristics, and responses to individual strains all vary.

    As a result, one probiotic may improve digestion for some people, have little noticeable effect for others, and cause unpleasant symptoms in a third group.

    The NIH emphasizes that probiotic effects depend on the specific strains and the conditions in which they are used.

    2. Fermentation of additional ingredients

    One of the clearest reasons for increased gas is the fermentation of certain carbohydrates by intestinal bacteria.

    Many combination products contain not only probiotics but also prebiotics—substances that microorganisms use as a food source.

    These may include:

    • Inulin.
    • Fructooligosaccharides (FOS).
    • Other fermentable dietary fibers.

    Bacterial fermentation produces gas. In sensitive people, this can increase bloating, abdominal pressure, and flatulence.

    According to research summarized by the NIH, some inulin-type prebiotics increased gas production in people with irritable bowel syndrome (IBS).

    Practical takeaway: If gas starts after taking a probiotic, check the complete ingredient list first. Added prebiotics may be responsible.

    3. Increased gut sensitivity

    Bloating does not always mean that an unusually large amount of gas is being produced.

    In irritable bowel syndrome and functional digestive disorders, symptoms may be linked to heightened sensitivity to normal stretching of the intestinal wall, altered motility, and interactions between the gut and nervous system.

    The 2025 European consensus on functional bloating emphasizes that the intensity of discomfort does not always match the actual volume of intestinal gas.

    Even relatively small changes in digestive processes can therefore cause considerable discomfort.

    4. The wrong strain or product formulation

    Probiotics are not one uniform category with identical effects.

    Different strains have different properties. Results from studies of one strain cannot automatically be applied to another.

    The 2025 European consensus highlights this distinction: certain probiotics may reduce bloating, but their effects vary and depend on the specific product.

    That is why a label stating “50 billion CFU” or “20 beneficial strains” does not, by itself, guarantee effectiveness or good tolerability.

    5. Underlying digestive problems

    Bloating may be related to more than the supplement being taken.

    Possible causes include irritable bowel syndrome, intolerance to particular carbohydrates, constipation, motility disorders, and other digestive conditions.

    Sometimes symptoms happen to coincide with starting a probiotic even though the underlying cause is independent of the product.

    This is why persistent or severe bloating should not automatically be dismissed as “adjusting to beneficial bacteria.”

    What does research say about probiotics and bloating?

    In 2025, the United European Gastroenterology Journal published a European consensus on the diagnosis and management of functional abdominal bloating.

    The experts reached several important conclusions:

    • Certain probiotics can reduce bloating.
    • Results differ substantially between products.
    • The benefits of individual probiotics are often modest and vary between people.
    • There is not enough evidence to recommend all probiotic products as a universal solution for bloating.

    The document also notes that research findings on prebiotics and bloating are mixed, and some fermentable ingredients can worsen symptoms.

    The literature therefore confirms an important point: products intended to support gut health do not always deliver the digestive comfort people expect.

    How can you reduce bloating after taking probiotics?

    If symptoms begin after starting a new supplement, it makes sense to check several factors systematically.

    Ingredients. Does the product contain inulin, FOS, or other fermentable components?

    Strains. Are the specific bacteria identified, and are there clinical studies of that particular combination?

    Dosage. Does it match the manufacturer’s directions? Increasing the number of bacteria does not necessarily improve the result.

    Tolerability. Is there a clear timing relationship between taking the product and developing symptoms?

    If symptoms persist or worsen, stop taking the supplement and discuss the situation with a healthcare professional. Severe pain, vomiting, blood in the stool, or unexplained weight loss requires medical evaluation.

    But there is a more fundamental question.

    Can we use the benefits of microbial preparations without some of the limitations associated with conventional probiotics?

    Postbiotics: why they are being considered as an alternative to probiotics

    The search for more stable and controlled ways to support the microbiome has helped advance the postbiotic approach.

    The goal has been to preserve beneficial biological activity from selected microorganisms while overcoming some drawbacks of conventional technology.

    Postbiotics are preparations of inactivated microorganisms and/or their components that confer a demonstrated health benefit.

    This approach makes it possible to:

    • Avoid dependence on keeping bacteria viable during storage.
    • Standardize the characteristics of a microbial preparation more precisely.
    • Use functional properties of microorganisms without administering viable bacterial cells.
    • Develop alternative formulations for people who do not tolerate certain conventional probiotics.

    In the context of bloating, the last possibility is particularly interesting: an approach to supporting gut health without introducing additional live probiotic microorganisms.

    This distinction alone, however, does not prove that every postbiotic causes less gas. The outcome depends on the specific preparation.

    Clinical study: can the benefits be preserved?

    In 2024, Gut Microbes published a randomized, double-blind study involving 200 people with diarrhea-predominant irritable bowel syndrome.

    Researchers compared live Bifidobacterium longum CECT 7347 (ES1), its heat-treated form HT-ES1, and placebo.

    After 84 days, the reductions in IBS symptom severity were:

    PreparationReduction in symptoms
    Live probiotic ES159.6%
    Heat-treated postbiotic HT-ES160.8%
    Placebo21.2%

    Both active groups showed statistically significant improvements compared with placebo (p < 0.0001).

    The central finding: the inactivated preparation retained clinically meaningful efficacy comparable to the live form of the same strain.

    The study did not establish postbiotic superiority and did not demonstrate that all postbiotics prevent bloating.

    But it did confirm an important possibility: some beneficial effects of microbial preparations can be preserved without administering viable bacteria.

    That is why the postbiotic approach merits further research in digestive comfort.

    Why NBHemp is investing in postbiotics

    At Nutraceutical Bio Hemp (NBHemp), we believe that microbiome-support products should evolve beyond simply increasing bacterial counts and instead focus on stability, reproducible composition, and ease of use.

    We are particularly interested in people with sensitive digestion and those who do not tolerate certain conventional probiotics well.

    These principles informed the development of NBH Postbiotic Pro, a product based on the postbiotic approach to supporting gut health.

    Conclusion: what if probiotics make you bloated?

    Gas and bloating after taking probiotics are recognized potential side effects. Their causes may involve the microbiota, product ingredients, or underlying digestive conditions.

    The first step is to identify the likely cause and examine the supplement’s complete formulation.

    But when the problem is related to tolerating the conventional probiotic approach, postbiotics deserve consideration as a technologically different alternative.

    Their promise lies in using beneficial properties of microbial preparations while overcoming some limitations of probiotics.

    For us, this is another reason to view postbiotics as the next generation of microbiome-support technologies.


    Scientific references

    1. NIH Office of Dietary Supplements. Probiotics: Fact Sheet for Health Professionals. Evidence on efficacy, strain specificity, and probiotic side effects.
      https://ods.od.nih.gov/factsheets/Probiotics-HealthProfessional/
    2. Melchior C. et al., 2025. European Consensus on Functional Bloating and Abdominal Distension — ESNM/UEG Recommendations for Clinical Management. United European Gastroenterology Journal.
      https://doi.org/10.1002/ueg2.70098
    3. NIH NCCIH. Irritable Bowel Syndrome and Complementary Health Approaches: What the Science Says.Research on probiotics, prebiotics, and gas.
      https://www.nccih.nih.gov/health/providers/digest/irritable-bowel-syndrome-and-complementary-health-approaches-science
    4. Salminen S. et al., 2021. ISAPP Consensus Statement on the Definition and Scope of Postbiotics. Nature Reviews Gastroenterology & Hepatology.
      https://doi.org/10.1038/s41575-021-00440-6
    5. Gut Microbes, 2024. A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live Bifidobacterium longum CECT 7347 (ES1) and heat-treated Bifidobacterium longum CECT 7347 (HT-ES1) in participants with diarrhea-predominant irritable bowel syndrome.
      https://pubmed.ncbi.nlm.nih.gov/38630015/
  • Postbiotics vs. Probiotics: Why Postbiotics Are the Next Generation

    Can we preserve the benefits of probiotics while eliminating the problems associated with their use? The search for an answer to this question led to the development of a new field: postbiotics.

    For decades, probiotics have been regarded as one of the main tools for supporting gut health. They have been used to restore microbial balance, improve digestion, and support the immune system.

    And there were good reasons for this. Research has indeed confirmed the benefits of certain probiotic strains for some digestive disorders, including antibiotic-associated diarrhea and specific symptoms of irritable bowel syndrome.

    Probiotics grew in popularity. Manufacturers offered more strains, increased the number of bacteria per serving, and developed new combinations.

    However, it gradually became clear that increasing the number of bacteria did not always mean increasing the benefits.

    The problem was not the idea of supporting the gut microbiota itself. The problem lay in the limitations of the traditional way of implementing it.

    What is the main difference between postbiotics and probiotics?

    Probiotics are a traditional approach to supporting the gut microbiome, whose effectiveness depends on specific strains, formulation, and individual characteristics. Postbiotics represent the next stage in the development of this approach: preserving the beneficial properties of microbial preparations while overcoming some of the limitations of probiotics—instability, difficulties with standardization, and tolerability issues. This is why NBHemp considers postbiotics a more promising technology for supporting gut health.

    What Went Wrong with Probiotics?

    Years of use and clinical research have revealed several significant problems.

    1. Unpredictable Results

    The same probiotic product may have a noticeable effect on one person and produce virtually no result in another.

    The reason is that each person’s gut microbiota is unique. Microbial composition, diet, digestive health, and other factors can influence the body’s response.

    Moreover, the beneficial properties of one bacterial strain cannot automatically be attributed to another.

    Therefore, even a high-quality probiotic may not be suitable for a particular individual.

    2. Bloating, Gas, and Discomfort

    Paradoxically, products intended to improve digestion can themselves cause unpleasant sensations in some people.

    Certain probiotics may cause gas, bloating, and temporary digestive discomfort.

    This issue is particularly relevant for people with sensitive digestive systems, in whom even small changes in microbial activity may be accompanied by unpleasant symptoms.

    As a result, an attempt to help the gut sometimes places an additional burden on the digestive system.

    3. The Challenge of Maintaining Consistent Quality

    Probiotics require microorganisms to remain viable throughout their stated shelf life.

    Temperature, humidity, transportation, and storage conditions can affect the number of active bacteria.

    Modern technologies successfully address many of these challenges, but monitoring viability remains an essential manufacturing requirement.

    4. Billions of Bacteria Do Not Guarantee Results

    The number of microorganisms in probiotics is usually expressed in CFU—colony-forming units.

    Labels may list 10, 50, or even 100 billion CFU.

    To consumers, this sounds convincing: the more bacteria, the better.

    But scientific research shows that this is not a reliable way to choose a product.

    Results depend primarily on the specific strain, its properties, dosage, and clinically demonstrated efficacy—not on the largest number printed on the package.

    5. Limitations for Certain Groups of People

    Most common probiotics are well tolerated by healthy individuals.

    However, using live microorganisms requires additional caution in people with serious illnesses or severely weakened immune systems.

    This is another factor limiting the universal applicability of the traditional approach.

    The Central Question: How Can We Preserve the Benefits While Eliminating the Drawbacks?

    All of these problems gradually led researchers to a fundamental question.

    If the benefits of probiotics arise from their interactions with the gut, immune system, and microbiota, is it necessary to reproduce the traditional mechanism of administration?

    Could we preserve the biologically beneficial properties of microorganisms while eliminating the technological and practical limitations associated with probiotics?

    In other words, the goal was not to abandon the achievements of probiotic science.

    Quite the opposite.

    The goal was to apply the knowledge already gained to develop more stable, controllable, and convenient products.

    One of the most promising answers to this question has been postbiotics.

    Postbiotics: The Next Stage in Microbiome Technology

    Postbiotics are based on the use of specially prepared microorganisms and their functional components.

    During manufacturing, specific microbial strains are selected and grown under controlled conditions, then processed in a way that preserves the preparation’s necessary biological properties.

    This makes it possible to use microbial material without requiring the bacteria to remain viable.

    That fundamentally changes the technology.

    Instead of having to maintain a specified number of live microorganisms, manufacturers can focus on standardizing composition, controlling functional components, and ensuring the reproducibility of the finished product’s properties.

    In 2021, the international scientific association ISAPP established a definition of postbiotics as preparations of inactivated microorganisms and/or their components that provide a demonstrated health benefit.

    Postbiotics have therefore become an independent scientific and technological field rather than simply another type of conventional probiotic.

    Which Problems Associated with Probiotics Can Postbiotics Address?

    Greater Technological Stability

    Postbiotic preparations do not require bacteria to remain viable.

    This can simplify storage and transportation, reduce the dependence of product quality on maintaining microbial viability, and expand the possibilities for creating convenient pharmaceutical and dietary supplement formats.

    More Precise Control of Composition

    Standardized manufacturing allows producers to control the amount of microbial material and the characteristics of its components.

    This makes it possible to create preparations with reproducible specifications from batch to batch.

    For consumers, this means clearer product characteristics; for manufacturers, additional opportunities for quality control.

    A New Approach to Tolerability

    With postbiotics, there is no need to introduce additional viable microorganisms into the digestive system.

    This makes the postbiotic approach particularly interesting for people who experience discomfort when taking certain probiotics.

    However, tolerability depends on the particular formulation: the absence of viable bacteria does not, by itself, guarantee the absence of adverse reactions.

    The Ability to Preserve Beneficial Biological Activity

    This is the point of greatest scientific interest.

    It turns out that certain beneficial properties of microbial preparations can remain after the microorganisms have been processed.

    Consequently, some of the benefits of the traditional approach may potentially be reproduced in a more technologically stable form.

    But has this been demonstrated clinically?

    Yes. And some results deserve particular attention.

    Clinical Evidence: 200 Participants, 84 Days, and Nearly Identical Results

    In 2024, the journal Gut Microbes published the results of a randomized, double-blind, placebo-controlled trial.

    It involved 200 people with irritable bowel syndrome, predominantly characterized by diarrhea.

    Researchers compared:

    • A conventional probiotic based on Bifidobacterium longum CECT 7347 (ES1).
    • A postbiotic preparation of the same strain—HT-ES1.
    • Placebo.

    The study lasted 84 days.

    The results were particularly revealing.

    Reduction in the severity of irritable bowel syndrome symptoms:

    GroupChange over 84 days
    Probiotic ES1−59.6%
    Postbiotic HT-ES1−60.8%
    Placebo−21.2%

    Both active groups demonstrated statistically significant improvements compared with placebo.

    And here is what matters most.

    The postbiotic preparation produced almost the same result as the conventional probiotic form of the same strain.

    The difference between them was not established as clinical superiority of either form. But this is a fundamental finding for the development of postbiotic technologies.

    It shows that, in certain cases, clinically meaningful effectiveness of a microbial preparation can be preserved while using a more controlled technological approach.

    Moreover, by the end of the study, a reduction in abdominal pain of at least 30% was recorded in 88.06% of participants in the postbiotic group versus 28.79% in the placebo group.

    These are not merely theoretical arguments; they are measurable results from a clinical study.

    A Second Study: Postbiotics and Everyday Digestive Discomfort

    Another study examined the postbiotic beLP1, based on Lactiplantibacillus plantarum.

    The study enrolled 140 adults experiencing moderate digestive discomfort.

    Participants received either the postbiotic or placebo for 84 days.

    The main results showed a statistically significant improvement in the overall gastrointestinal symptom score in the postbiotic group:

    • On Day 42: p = 0.0215.
    • On Day 84: p = 0.0394.

    Improvements were also recorded in certain measures of abdominal pain, dyspepsia, and digestion-related quality of life.

    The researchers additionally observed changes in gut microbiota composition, including an increase in the relative abundance of certain microorganisms associated with the production of short-chain fatty acids.

    The final per-protocol analysis included 103 participants.

    This study matters for another reason: it shows that the postbiotic approach is of interest not only as a comparison with probiotics but also as an independent approach to supporting digestive comfort.

    What Has Changed in Our Understanding of Gut Health Support?

    Until recently, consumers were often encouraged to judge a probiotic mainly by the billions of bacteria it contained and the number of different strains.

    Today, it is becoming clear that these are far from the most informative criteria.

    It is much more important to understand what a particular microbial preparation does, how stable its composition is, and whether research supports its benefits.

    Postbiotics make it possible to shift the focus from the quantity of microorganisms to the functional properties and quality of the finished product.

    We consider this shift one of the most significant changes in the development of microbiome technologies.

    Probiotics opened up enormous possibilities for using beneficial microorganisms.

    Postbiotics offer a way to build on those achievements while overcoming some of the technological and practical limitations of the earlier approach.

    Why NBHemp Chose to Focus on Postbiotics

    Nutraceutical Bio Hemp (NBHemp), which has operated since 2018, is developing its own line of products to support the health of the gut microbiome.

    In choosing a technology, we started with a straightforward goal:

    Preserve the benefits of microbiome support while reducing dependence on the factors that complicate the use of conventional probiotics.

    Four characteristics are especially important to us:

    • Stability of the finished product.
    • Standardized, controlled composition.
    • Convenience for regular use.
    • Attention to tolerability, particularly for people with sensitive digestion.

    These principles formed the foundation for the development of NBH Postbiotic Pro.

    This product represents a new direction that we see as a practical application of the postbiotic approach.

    At the same time, the results of studies involving other postbiotic formulations are not direct evidence of the effectiveness of Postbiotic Pro: the benefits of any specific product depend on its own composition and research findings.

    Our Conclusion: Why We Consider Postbiotics the Next Generation

    The history of probiotics is a story of an important scientific achievement.

    They helped us understand how closely human health is linked to intestinal microorganisms and demonstrated that influencing the microbiota can provide real benefits.

    But limitations also emerged: inconsistent results, individual tolerability issues, dependence on bacterial viability, and challenges with standardization.

    The development of postbiotics offers a new path.

    It makes it possible to use the functional properties of microbial preparations, create more stable products, and expand the possibilities for controlling their composition.

    Clinical research already shows that, for certain postbiotic preparations, this approach can produce meaningful beneficial effects.

    Our position is therefore clear: postbiotics are not merely an alternative to probiotics but the next stage in the development of technologies for supporting the gut microbiome.

    Not a rejection of the achievements of the past, but their further development.

    It is in this field that we see considerable potential for modern microbiome science.

    Scientific References

    1. Salminen S. et al. (2021). The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nature Reviews Gastroenterology & Hepatology.
    https://doi.org/10.1038/s41575-021-00440-6

    2. A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live Bifidobacterium longum CECT 7347 (ES1) and heat-treated Bifidobacterium longum CECT 7347 (HT-ES1) in participants with diarrhea-predominant irritable bowel syndrome. Gut Microbes, 2024.
    https://pubmed.ncbi.nlm.nih.gov/38630015/

    3. Gut health and microbiome modulation by the heat-killed postbiotic beLP1® in adults with excess weight: a randomized, placebo-controlled trial. 2026.
    https://pubmed.ncbi.nlm.nih.gov/42824179/

    4. NIH Office of Dietary Supplements. Probiotics — Fact Sheet for Health Professionals.
    https://ods.od.nih.gov/factsheets/Probiotics-HealthProfessional/

    5. National Center for Complementary and Integrative Health (NCCIH). Probiotics: Usefulness and Safety.
    https://www.nccih.nih.gov/health/probiotics-usefulness-and-safety

    Nbhemp Archive Materials

    The article draws on NBHemp’s archive of publications from previous years:

    • “Postbiotics: The Next Generation of Microbiome Support.”
    • “NBHemp Sensitive Postbiotic: A New Generation of Microbiome Support Products.”
    • Materials discussing the advantages of postbiotics in terms of stability, standardization, and tolerability.
    • Discussions of postbiotics in the context of SIBO and sensitive digestion.

    Related points have been combined and repetitions removed. Additional clinical data are cited from the original scientific publications.